Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ravishankar, Bellala"'
Autor:
Ravishankar, Bellala, Madhavi, Bellala Venkata, Kalagara, Akash, Bodepudi, Srija, Harnadh, Sriharsha, Bindu, P.Josephine, Pydi, Venkateswar Rao, Raj, Bellala Prithvi, Nitya, Gopireddy, Rishik, Bellala
Publikováno v:
In Pathology - Research and Practice January 2024 253
Autor:
Ravishankar, Bellala1 (AUTHOR) ravi_bellala@yahoo.co.in, Madhvi, Bellala Venkata1 (AUTHOR), Tyagi, Tulika1 (AUTHOR), Srivastava, Vishy2 (AUTHOR), Kuppusamy, Anandakrishnan1 (AUTHOR), Prithviraj, Bellala3 (AUTHOR), Rishik, Bellala4 (AUTHOR)
Publikováno v:
Journal of Current Oncology. Dec2022, Vol. 5 Issue 2, p111-118. 8p.
Autor:
null Madhavi Venkata Bellala, null Srikanth Dikkala, null Tulika Tyagi, null Prithviraj Bellala, null Rishik Bellala, null Ravishankar Bellala
Publikováno v:
International Journal of Scientific Research Updates. 3:010-021
Purpose: To depict the emergence of targeted therapies that have led to distinguished breakthrough in the management of cancer. Methods: The literature was systematically reviewed, based on their evolution and their use with understanding on the adve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad48995badb538076f578dccae2aef8c
https://doi.org/10.53430/ijsru.2022.3.1.0021
https://doi.org/10.53430/ijsru.2022.3.1.0021
Autor:
Ravishankar Bellala, T S Ganesan, Anita Ramesh, Neeraj Bhatt, Shilpa Kandipalli, Ashwin Kumar, Vijay Kumar, Kartikeya Jain, Shrikrishna Mandal, Mahesh Kumar Kalloli, Ben Yoon, Sunil Gupta, Srinivasa Rao Jada
Publikováno v:
Proceedings of the 38th Annual Meeting of Korean Society of Gynecologic Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b8bc9e42270bbfa80981029fc3b2861
https://doi.org/10.3802/jgo.2023.34.s1.tip07
https://doi.org/10.3802/jgo.2023.34.s1.tip07
Autor:
Chaiyut Charoentum, Fernanda Rafaela Garcia, Andric Zoran, Luis Figuero Pérez, Bojan Zaric, Felicitas Bullo, Igor Bondarenko, Ravishankar Bellala, Elena Poddubskaya, Serhii Shevnia, D. Trukhin
Publikováno v:
Journal of Clinical Oncology. 39:e15003-e15003
e15003 Background: Stella Trial is a phase III, multinational, double-blind and randomized study to confirm clinical similarity between MB02 and EU-bevacizumab in patients with stage IIIB/IV no squamous NSCLC. 627 subjects with newly diagnosed or rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ba7f3a00dc2a06790674b528dbc89c6
https://doi.org/10.1200/jco.2021.39.15_suppl.e15003
https://doi.org/10.1200/jco.2021.39.15_suppl.e15003
Autor:
Ravishankar Bellala, VenkataMadhavi Bellala, Dikkala Srikanth, Sivaramakrishna Talluri, PrithviRaj Bellala, Rishik Bellala
Publikováno v:
Journal of Current Oncology. 4:76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fdc30794e6bf170bf8928829e2813b9
https://doi.org/10.4103/jco.jco_31_21
https://doi.org/10.4103/jco.jco_31_21
Autor:
Bellala, Ravishankar1 ravi_bellala@yahoo.co.in, Kuppusamy, Anandakrishnan1, Bellala, Venkata Madhavi1, Tyagi, Tulika1, Manoharan, Surendhiran1, Gangarapu, Gunasekhar1, Bellala, Rishik1
Publikováno v:
Journal of Cancer Research & Therapeutics. Jul-Sep2023, Vol. 19 Issue 5, p1160-1169. 10p.